Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07386444 · ClinicalTrials.gov registry record · NA
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
A NA study of Dyspnea and Early Stage Breast Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT07386444: Recruiting NA study of Dyspnea and Early Stage Breast Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.
NCT07386444 is a NA study of Dyspnea and Early Stage Breast Carcinoma that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 58 participants, below the 303-participant average among 23 other Dyspnea trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07386444, a NA study of Dyspnea and Early Stage Breast Carcinoma, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies whether breathing exercises for the muscles that help with breathing air in, inspiratory muscle training (IMT), works to improve breathing muscle strength, shortness of breath, and physical activity levels in women who are receiving chemotherapy for early-stage breast cancer (BC). Cancer and/or treatments for BC can directly result in muscle wasting that involves breathing muscles, skeletal muscles or heart muscles. Pain, weakness, shortness of breath, and side effects of cancer treatment may lead to lower physical activity levels. IMT involves breathing exercises using a small hand-held device. The device makes it a little harder to breathe in, which may help strengthen breathing muscles. IMT may be an effective way to improve breathing muscle strength, shortness of breath, and physical activity levels in women who are receiving chemotherapy for early-stage BC.
Primary Outcome
Measure of the strength of the inspiratory muscles. Units: cm H20
Conditions Studied
Interventions
- BEHAVIORAL Inspiratory muscle training
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2026-02-19 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT07386444 shows while recruiting
NCT07386444 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 303-participant average among 23 other Dyspnea trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Dyspnea appearing as the primary indexed condition, and to 1 intervention - of which Inspiratory muscle training is the first listed.
NCT07386444 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07386444 about?
NCT07386444 is a clinical study titled "Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy". This clinical trial studies whether breathing exercises for the muscles that help with breathing air in, inspiratory muscle training (IMT), works to improve breathing muscle strength, shortness of breath, and physical activity levels in women who are receiving chemotherapy for early-stage breast can...
What is the current status of trial NCT07386444?
This trial is currently recruiting. It is a NA study. The enrollment target is 58 participants. The study started on 2026-02-19. Estimated completion is 2026-12-31.
What conditions does trial NCT07386444 study?
This clinical trial studies the following conditions: Dyspnea, Early Stage Breast Carcinoma.
What interventions are being tested in trial NCT07386444?
The interventions under investigation include: Inspiratory muscle training (BEHAVIORAL).
Who is sponsoring clinical trial NCT07386444?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07386444 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07386444's enrollment target sits among peer trials
58 13th of 23 higher than 11 of 23 other Dyspnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dyspnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Breathlessness Relieved by Employing Medical Air to be Titrated by Hospitalized Patients to Improve Inpatient Experience
ACTIVE NOT RECRUITING · NA
-
Improving Management of Breathlessness in Patients With Lung Cancer
COMPLETED · NA
-
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
COMPLETED · NA
-
Evaluation of Breathing Pattern and Dyspnea in Subjects With Tetraplegia
COMPLETED · NA
-
Improving Care of Patients With Heart Failure
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI